Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06970925 · ClinicalTrials.gov registry record · Early Phase 1
Pilot Study Evaluating the Advantages of Sucrosomial® Iron Post-operative Supplementation vs Standard of Care After Cardiac Surgery
A Early Phase 1 study of Cardiac Surgery, sponsored by Englewood Hospital and Medical Center.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06970925 is a Early Phase 1 study of Cardiac Surgery that is actively recruiting participants, run by Englewood Hospital and Medical Center. The registered enrollment target is 40 participants, below the 743-participant average among 19 other Cardiac Surgery trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06970925, a Early Phase 1 study of Cardiac Surgery, is actively recruiting participants, sponsored by Englewood Hospital and Medical Center.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Primary objective: to evaluate the non-inferiority in terms of improvement of hemoglobin (Hg) levels within 30 days postoperatively between two proposed treatments. Secondary objective: to evaluate the financial costs associated with Sucrosomial® Iron treatment compared to Iron Sucrose (IV), while demonstrating non-inferiority in the improvement of hemoglobin levels, reduction in transfusion requirements, and reduction of hospital/ICU stay length
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Sucrosomial Iron (SI)
Study Locations (1)
New Jersey
- Englewood Hospital - Englewood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-06-30 |
| Est. Completion | 2026-06-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06970925
The ClinicalTrials.gov registry entry for NCT06970925 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 743-participant average among 19 other Cardiac Surgery trials with a reported enrollment target (95% lower). The listed sponsor is Englewood Hospital and Medical Center, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cardiac Surgery appearing as the primary indexed condition, and to 1 intervention - of which Sucrosomial Iron (SI) is the first listed.
NCT06970925 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT06970925 about?
NCT06970925 is a clinical study titled "Pilot Study Evaluating the Advantages of Sucrosomial® Iron Post-operative Supplementation vs Standard of Care After Cardiac Surgery". Primary objective: to evaluate the non-inferiority in terms of improvement of hemoglobin (Hg) levels within 30 days postoperatively between two proposed treatments. Secondary objective: to evaluate the financial costs associated with Sucrosomial® Iron treatment compared to Iron Sucrose (IV), while ...
What is the current status of trial NCT06970925?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 40 participants. The study started on 2025-06-30. Estimated completion is 2026-06-30.
What conditions does trial NCT06970925 study?
This clinical trial studies the following conditions: Cardiac Surgery.
What interventions are being tested in trial NCT06970925?
The interventions under investigation include: Sucrosomial Iron (SI) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06970925?
This trial is sponsored by Englewood Hospital and Medical Center, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06970925 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ESP/PIF for Sternotomy
ACTIVE NOT RECRUITING · Early Phase 1
-
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
RECRUITING · NA
-
Oral Methadone in Cardiac Surgery
RECRUITING · Phase 4
-
Cardiopulmonary Bypass Induced Red Blood Cell Lysis
RECRUITING
-
Assessing the Burden of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
RECRUITING
-
Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.